Biotech

All Articles

A deeper check out Ferocious Biotech's Tough 15

.In this full week's incident of "The Top Line," we are actually diving in to Intense Biotech's year...

Lilly experiences phase 2 failing of tau-targeting med

.The confetti is actually still soaring from Eli Lilly's celebration commemorating the approval of A...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, firings an...

Lykos will certainly talk to FDA to rethink its own decision complying with rejection of MDMA therapy for post-traumatic stress disorder

.Adhering to an inadequate showing for Lykos Rehabs' MDMA prospect for trauma at a latest FDA adviso...

AN 2 one-halfs census, quits period 3 test after information disappoint

.AN2 Therapies is actually reconsidering its own organization in action to uninspired midphase infor...

Merck pays out $700M for bispecific, spying autoimmune opening and opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is paying for $700 thousand beforehand to challenge Amgen in a blood cancer cells ma...

Gilead pays J&ampJ $320M to go out licensing offer for seladelpar

.Along With Gilead Sciences about to an FDA selection for its own liver illness medication seladelpa...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may view the providers putting together camping tents at basecamp responsible for E...

Entero giving up team, moving out of office and also pausing R&ampD

.Bed mattress Liquidators has actually transformed Entero Therapeutics white as a sheet. The collect...

Exelixis drops ADC after determining it is actually no match for Tivdak

.Exelixis is actually quiting on its tissue aspect (TF)- targeting antibody-drug conjugate after con...